Glycinebetaine

Glycinebetaine

SCHEMBL21647161

CC(C)(N)C(=O)O.C[N+](C)(C)CC(=O)[O-].C[N+](C)(C)CC(=O)[O-]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BHMTBHMT2

The experimentally established mechanism targets of Glycinebetaine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.42
ALDH1A1 P00352 2/20 0.41
LMNA P02545 1/20 0.41
APEX1 P27695 1/20 0.41
CPT2 P23786 1/20 0.36
CPT1A P50416 1/20 0.36
SLC22A16 Q86VW1 1/20 0.34
GGT1 P19440 1/20 0.32
BBOX1 O75936 2/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C19 P33261 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glycinebetaine SCHEMBL22499790 1.00 TSHR (0.42) TSHRALDH1A1LMNAAPEX1CPT2
Glycinebetaine SCHEMBL6673018 0.81 TSHR (0.50) TSHRALDH1A1LMNAAPEX1CPT2
Glycinebetaine SCHEMBL9281697 0.81 TSHR (0.55) TSHRALDH1A1LMNAAPEX1CPT2
Glycinebetaine SCHEMBL9116728 0.81 TSHR (0.48) TSHRALDH1A1LMNAAPEX1CPT2
Glycinebetaine SCHEMBL4900209 0.81
Glycinebetaine SCHEMBL8678519 0.81 TSHR (0.53) TSHRALDH1A1LMNAAPEX1CPT2
Betaine SCHEMBL31467313 0.81
Glycinebetaine SCHEMBL7739 0.81
Glycinebetaine SCHEMBL2803780 0.81 TSHR (0.53) TSHRALDH1A1LMNAAPEX1CPT2
Glycinebetaine SCHEMBL11906100 0.79 TSHR (0.48) TSHRALDH1A1LMNAAPEX1CPT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020024703-A1 WATER-SOLUBLE FULLERENE TOPICAL COMPOSITION 北京福纳康生物技术有限公司 2020-02-06 WO disclosed